Antoni Van Leeuwenhoek Hospital, Amsterdam
Risk of breast cancer increased after diagnosis of salivary gland tumor
Published in Disease Risk Factor Week, August 28th, 2005
According to recent research from the Netherlands, "The aim of this study was to evaluate whether patients with salivary gland tumors are at increased risk of developing breast cancer. A retrospective cohort study was performed."
"Female patients (n=439) with a salivary gland tumor (major and minor) were included. The diagnosis was confirmed histologically. The median follow-up was 5.4 years. Fifteen patients out of 439 with a salivary gland tumor subsequently developed breast cancer, with a mean time interval of 64 months. On the basis of incidence rates in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- CHUR Dupuytren
Anti-papillomavirus vaccines and prevention of cervical cancer reviewed - City of New York Mount Sinai School of Medicine
Topical microbicides needed for prevention of genital herpes infections - Emory University, Atlanta
Low health literacy associated with HIV test acceptance - Harvard Health Publications
Dietary fiber helps prevent colon cancer - 454 Life Sciences
Life science instrumentation maker gets $11.5M in milestones - AVANT Immunotherapeutics, Inc.
Positive preliminary results from clinical trial of cholera vaccine reported - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
